New Launch - One Sophia For Sale!

New Launch - One Sophia For Sale!
Please click the advertisement for more information.

Search This Blog

Tuesday, January 4, 2022

Koufu - Stock calls

Date

Analyst

Company

Last

Target

Call

Valuation

01/06/21

DBS Vickers

Koufu

0.685

0.77

Buy


02/25/21

UOB Kay Hian

Koufu

0.665

0.77

Buy


02/25/21

DBS Vickers

Koufu

0.665

0.77

Buy

PER17x FY21

03/01/21

Phillip

Koufu

0.66

0.68

Accumulate

PER18.5x FY21, Cut from $0.77

03/01/21

CIMB

Koufu

0.66

0.94

Add


03/15/21

UOB Kay Hian

Koufu

0.665

0.77

Buy


05/18/21

DBS Vickers

Koufu

0.63

0.77

Buy

PER17x FY21

05/24/21

Phillip

Koufu

0.63

0.64

Neutral

PER18.5x FY21

06/07/21

CIMB

Koufu

0.655

0.71

Hold

PER17x FY22

08/11/21

Lim & Tan

Koufu

0.65

0

Hold


08/12/21

UOB Kay Hian

Koufu

0.67

0.77

Buy


08/13/21

CIMB

Koufu

0.675

0.8

Add


08/13/21

SAC Capital

Koufu

0.675

0.775

Buy

DCF, PER15.8x FY22

09/06/21

Phillip

Koufu

0.65

0.64

Neutral

PER18.5x FY21

09/06/21

SAC Capital

Koufu

0.65

0.775

Buy

DCF, PER15.8x FY22

09/28/21

CIMB

Koufu

0.635

0.8

Add


10/12/21

Kim Eng

Koufu

0.645

0.78

Buy

PER18x FY22

10/14/21

UOB Kay Hian

Koufu

0.66

0.77

Buy


11/26/21

Lim & Tan

Koufu

0.69

0.73

Hold


12/01/21

DBS Vickers

Koufu

0.665

0.78

Buy


12/14/21

UOB Kay Hian

Koufu

0.67

0.77

Buy

PER17x FY22

12/30/21

Lim & Tan

Koufu

0.665

0.77

Accept Offer

Offer $0.77

Koda - Stock calls

Date

Analyst

Company

Last

Target

Call

Valuation

07/23/21

Phillip

Koda

0.8

1.32

Buy

PER7x FY21, Ex-cash

07/30/21

SAC Capital

Koda

0.86

1.02

Hold


08/30/21

Phillip

Koda

0.805

1.1

Buy

PER7x FY22, Ex-cash

Kimly - Stock calls

Date

Analyst

Company

Last

Target

Call

Valuation

01/19/21

DMG & Partners

Kimly

0.335

0.39

Buy


05/14/21

DMG & Partners

Kimly

0.345

0.42

Buy


06/21/21

CIMB

Kimly

0.38

0.46

Add

PER16.8x FY22

06/30/21

DMG & Partners

Kimly

0.4

0.48

Buy


09/28/21

CIMB

Kimly

0.38

0.46

Add


11/18/21

DBS Vickers

Kimly

0.375

0.5

Buy

PER15x FY22

11/18/21

DMG & Partners

Kimly

0.375

0.42

Buy


12/01/21

DBS Vickers

Kimly

0.415

0.5

Buy


12/15/21

UOB Kay Hian

Kimly

0.41

0.41

Hold

PER16x FY22

01/04/22

CIMB

Kimly

0.405

0.56

Add

K

Stock calls for 4 January 2022

Date

Analyst

Company

Last

Target

Call

Valuation

01/04/22

UOB Kay Hian

CDL Hospitality

1.2

1.42

Buy

DDM

01/04/22

Lim & Tan

Golden Energy

0.295

0.42

Buy


01/04/22

CIMB

Kimly

0.405

0.56

Add


01/04/22

Lim & Tan

Stamford Land

0.365

0

Subscribe rights

Rights @ $0.34

01/04/22

DMG & Partners

Venture

18.45

20.9

Buy


Sinovac shot gives no shield for Omicron? - Part 4

https://www.theguardian.com/australia-news/2022/jan/04/t-cells-can-fight-omicron-when-antibodies-fail-to-australian-researchers-say 

Aussie researchers have just stated that T-cell can fight omicron!

This is a piece of good news for Sinovac because it triggers T-cell activation against omicron.

http://sg-stock.blogspot.com/2022/01/sinovac-shot-gives-no-shield-for.html

China PMI had improved again in December 2021.

https://sg.finance.yahoo.com/news/chinse-manufacturing-grows-unexpectedly-faster-234236539.html

China PMI increased to 50.3 in December 2021.  The Chinese manufacturing continued to grow as we had projected but many analysts had expected China PMI to decline because of the upcoming winter Olympics as manufacturing was restricted to reduce air pollution.  We had our own rationale for our optimism which we had stated below and we were proven right again.


"We continue to have our optimism as the manufacturing sector has to meet consumer demands for the upcoming CNY festival."

Monday, January 3, 2022

Sinovac shot gives no shield for Omicron? - Part 3

https://www.theedgemarkets.com/article/sinovac-booster-dose-can-activate-cellular-immunity-against-omicron-variant

The latest research showed that the Sinovac booster could trigger T-cell activation which is able to recognize and destroy omicron.  T-Cell is a long-term memory immunity cell that is better than neutralizing antibodies.  Neutralizing antibodies' task is to bind themselves to the virus to block or prevent virus multiplication.  As for B cells, they're capable to destroy infected cells in our bodies.  In a nutshell, T-cell is more important than antibodies but many types of research just focus on the number of antibodies instead of T-cell.

The latest vaccine update is Astrazeneca has no effect on symptomatic omicron.